Apothecon Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Taluka Padra, Gujarat, India, established in 2007.
2007 Taluka Padra, Gujarat, India Active
Last Updated:
Access Report
About Apothecon Pharmaceuticals Private Limited

Apothecon Pharmaceuticals Private Limited, a active private limited company, was established on 14 May 2007 in Taluka Padra, Gujarat, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24232GJ2007PTC050825. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹8.48 M.

Formerly known as Navinta Healthcare Private Limited. It upholds a compliant status. Employing 651 professional, Its leadership includes Dilipkumar Ramsingbhai Parmar (Whole-Time Director), Rajajeyakumar (Whole-Time Director), Jayeshkumar Kodarlal Joshi (Director). Past directors included Chirag Jitendra Shah, Nirmal Tarun Parikh, Mahendra Raojibhai Patel. It holds ₹358.31 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No.1134 To 1137, 1138 A&B,1143 A&B,1144 A&B Padra-Jambusar Highway, At & Post:-Dabha, Sa,, Taluka Padra, Gujarat, 391440.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232GJ2007PTC050825

  • Registration Number

    050825

  • Incorporation Date

    14 May 2007

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹8.48 M

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 8.48 M
  • Company Age 18 Year, 10 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 358.31 Cr
  • Revenue Growth **** 9.77%
  • Profit Growth **** -28.56%
  • Ebitda **** -7.87%
  • Net Worth 13.02%
  • Total Assets **** 25.92%
Company report

Apothecon Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Apothecon Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Apothecon Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Dilipkumar Ramsingbhai Parmar Whole-Time Director 30 Jun 2020 Current
Rajajeyakumar Whole-Time Director 01 Jul 2017 Current
Jayeshkumar Kodarlal Joshi Director 15 Apr 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2011 Past
Pramod Abcsdd Director 01 Jun 2018 Past
Pramod Abcsdd Director 21 May 2011 Past
Pramod Abcsdd Director 25 Jan 2010 Past
Pramod Abcsdd Additional Director 01 Sep 2020 Past
Pramod Abcsdd Director 07 Apr 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Apothecon Pharmaceuticals.

Apothecon Pharmaceuticals Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 9.77% increase. The company also saw a substantial fall in profitability, with a 28.56% decrease in profit. The company's net worth Soared by an impressive increase of 13.02%.

Apothecon Pharmaceuticals revenue growth over time
Apothecon Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 9.77%
*******
*******
*******
*******
Revenue from Operations
*******
 8.71%
*******
*******
*******
*******
Total Assets
*******
 25.92%
*******
*******
*******
*******
Profit or Loss
*******
 -28.56%
*******
*******
*******
*******
Net Worth
*******
 13.02%
*******
*******
*******
*******
EBITDA
*******
 -7.87%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Apothecon Pharmaceuticals?

In 2024, Apothecon Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹3,583,124,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • State Bank Of India : 338.41 Cr
  • Hdfc Bank Limited : 19.90 Cr
Latest Charge Details
Date Lender Amount Status
20 Nov 2025 Hdfc Bank Limited ₹1.27 M Open
29 Aug 2025 Hdfc Bank Limited ₹4.47 M Open
19 Jul 2025 Hdfc Bank Limited ₹2.12 M Open
25 Mar 2025 Hdfc Bank Limited ₹18.00 Cr Open
27 Jan 2025 State Bank Of India ₹78.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Apothecon Pharmaceuticals?

Apothecon Pharmaceuticals has a workforce of 651 employees as of Feb 17, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Apothecon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apothecon Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Apothecon Pharmaceuticals
Recent Activity within the Organization
  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 0.13 Cr with Charge ID 101187236 was registered on 20 Nov 2025. was completed.

  • Annual General Meeting

    Apothecon Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 0.45 Cr with Charge ID 101146354 was registered on 29 Aug 2025. was completed.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 0.21 Cr with Charge ID 101128900 was registered on 19 Jul 2025. was recorded as a recent event.

  • Balance Sheet

    Progress on Apothecon Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was documented.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 18.00 Cr with Charge ID 101077271 was registered on 25 Mar 2025. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Apothecon Pharmaceuticals Private Limited?

The CIN of Apothecon Pharmaceuticals Private Limited is U24232GJ2007PTC050825.

Where is Apothecon Pharmaceuticals Private Limited headquartered?

Apothecon Pharmaceuticals Private Limited is headquartered at Plot No.1134 To 1137, 1138 A&B,1143 A&B,1144 A&B Padra-Jambusar Highway, At & Post:-Dabha, Sa,, Taluka Padra, Gujarat, 391440.

When was Apothecon Pharmaceuticals Private Limited incorporated?

Apothecon Pharmaceuticals Private Limited was incorporated on 14 May 2007.

Who are the current directors of Apothecon Pharmaceuticals Private Limited?

The current directors of Apothecon Pharmaceuticals Private Limited are

What is the primary industry of Apothecon Pharmaceuticals Private Limited?

The primary industry of Apothecon Pharmaceuticals Private Limited is Manufacturing.

Is Apothecon Pharmaceuticals Private Limited a listed company?

Apothecon Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Apothecon Pharmaceuticals Private Limited?

The authorized capital of Apothecon Pharmaceuticals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹8.48 M.

What is the compliance status of Apothecon Pharmaceuticals Private Limited?

The compliance status of Apothecon Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available